小儿肺咳颗粒治疗小儿支原体肺炎的临床疗效及其对炎性因子的影响
2022-03-25缐红梅
缐红梅
【摘 要】目的:分析对小儿支原体肺炎患儿应用小儿肺咳颗粒的治疗效果,并观察患儿血清炎性因子的变化。方法:对照组为常规西医治疗,同期观察组加用小儿肺咳颗粒治疗。结果:治疗总有效率观察组97.37%,对照组84.21%(P<0.05);治疗前两组血清CRP、IL-6、IL-10水平对比(P>0.05),治疗后血清CRP、IL-6、IL-10水平观察组较对照组更低(P<0.05)。结论:对于支原体肺炎患儿通过应用小儿肺咳颗粒的治疗效果满意,能够改善患儿血清炎性因子水平并显著提升治疗效果。
【关键词】支原体肺炎;小儿;小儿肺咳颗粒;疗效;炎性因子
Clinical efficacy of pediatric pulmonary cough particles in the treatment of pediatric Mycoplasma pneumoniae pneumonia and its effect on inflammatory factors
XIAN Hongmei
The People’s Hospital of Kangle County, Linxia, Gansu 731500, China
【Abstract】Objective: To analyze the treatment effect of pulmonary particles in children with mycoplasma pneumonia and observe the changes of seroinflammatory factors.Methods: The control group was conventional Western medicine, and the observation group was treated with pediatric pulmonary cough particles.Results: The total effective rate of treatment was 97.37% in the observation group and 84.21% in the control group(P<0.05);the comparison of serum CRP, IL-6, IL-10 levels between the two groups before treatment(P>0.05), and the serum CRP, IL-6, IL after treatment The -10 level of the observation group was lower than that of the control group(P<0.05).Conclusion: The satisfactory treatment effect of children with mycoplasma pneumonia can improve the serum level of inflammatory factors and significantly improve the treatment effect.
【Key?Words】Mycoplasma pneumonia; Children; Children with pulmonary cough particles; Efficacy; Inflammatory factors
小兒支原体肺炎属于儿童阶段尤其是婴幼儿阶段发病率较高的呼吸系统疾病,患儿受到细菌或病毒的侵袭使得支气管黏膜出现急性炎症反应,并对呼吸系统产生刺激,产生大量分泌物,其症状为呼吸增快、肺部湿啰音、口周发绀等,甚至可诱发哮喘,威胁患儿的生命健康[1]。中医把小儿肺炎归为"咳嗽"和“肺炎喘嗽”范畴,小儿肺咳颗粒具备健脾益肺以及止咳平喘等功效,是对小儿支气管炎等疾病常用的中药,在改善周身乏力、痰多稠黄、气短喘促等症状方面有突出疗效。以下将分析对小儿支原体肺炎患儿通过应用小儿肺咳颗粒的治疗价值。
1.1 临床资料
抽取2019年3月至2021年8月本院76例支原体肺炎患儿,随机数字表法分组。观察组38例,男20例,女18例,年龄3岁~11岁,平均年龄(5.6±1.5)岁,发病时间1d~4d,平均时间(1.6±0.3)d;对照组38例,男19例,女19例,年龄3岁~12岁,平均年龄(5.7±1.4)岁,发病时间1d~4d,平均时间(1.5±0.4)d。两组各项基础资料具备可比性(P>0.05)。……
